Communications Medicine (Jan 2023)
B cell response after SARS-CoV-2 mRNA vaccination in people living with HIV
Abstract
Polvere et al. investigate B cell responses after SARS-CoV-2 vaccination in people living with HIV undergoing anti-retroviral therapy. Spike-specific humoral and B cell responses persist for at least six months although a reduced ACE2/RBD binding inhibition capacity and different memory B phenotypes are observed compared to healthy controls.